ifosfamide has been researched along with Histiocytoma, Benign Fibrous in 14 studies
Histiocytoma, Benign Fibrous: A benign tumor composed, wholly or in part, of cells with the morphologic characteristics of HISTIOCYTES and with various fibroblastic components. Fibrous histiocytomas can occur anywhere in the body. When they occur in the skin, they are called dermatofibromas or sclerosing hemangiomas. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 5th ed, p1747)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The current study was performed to evaluate the toxicity profile of therapeutic doses of ifosfamide (IFX) given concurrently with full-dose external beam radiotherapy (EBRT) in patients with soft tissue and bone sarcomas." | 8.81 | Concurrent ifosfamide-based chemotherapy and irradiation. Analysis of treatment-related toxicity in 43 patients with sarcoma. ( Ballo, MT; Benjamin, RS; Burgess, MA; Cormier, JN; Feig, BW; Herzog, CE; Hunt, KK; Patel, SR; Pisters, PW; Raney, RB; Zagars, GK, 2001) |
| "To assess the impact of different factors on response rate (RR), time to tumor progression (TTP), and overall survival time (OS) in patients with locally advanced or metastatic soft tissue sarcoma (ASTS), included in three protocols with high-dose ifosfamide (HDIF)." | 7.72 | Salvage surgical resection after high-dose ifosfamide (HDIF) based regimens in advanced soft tissue sarcoma (ASTS): a potential positive selection bias--a study of the Spanish group for research on sarcomas (GEIS). ( Balañá, C; Buesa, J; Casado, A; de Las Peñas, R; del Muro, XG; López-Pousa, A; Martín, J; Martínez-Trufero, J; Maurel, J; Quintana, MJ, 2004) |
| "From January 1990 to December 1995 we treated 35 patients (pts) with bone and soft tissue sarcoma with ifosfamide (IFM)." | 7.69 | [The effects of high-dose ifosfamide in the treatment of bone and soft tissue sarcomas]. ( Ishii, T; Kitoh, M; Satoh, T; Tatezaki, S; Umeda, T; Yonemoto, T, 1997) |
| "The current study was performed to evaluate the toxicity profile of therapeutic doses of ifosfamide (IFX) given concurrently with full-dose external beam radiotherapy (EBRT) in patients with soft tissue and bone sarcomas." | 4.81 | Concurrent ifosfamide-based chemotherapy and irradiation. Analysis of treatment-related toxicity in 43 patients with sarcoma. ( Ballo, MT; Benjamin, RS; Burgess, MA; Cormier, JN; Feig, BW; Herzog, CE; Hunt, KK; Patel, SR; Pisters, PW; Raney, RB; Zagars, GK, 2001) |
| "To assess the impact of different factors on response rate (RR), time to tumor progression (TTP), and overall survival time (OS) in patients with locally advanced or metastatic soft tissue sarcoma (ASTS), included in three protocols with high-dose ifosfamide (HDIF)." | 3.72 | Salvage surgical resection after high-dose ifosfamide (HDIF) based regimens in advanced soft tissue sarcoma (ASTS): a potential positive selection bias--a study of the Spanish group for research on sarcomas (GEIS). ( Balañá, C; Buesa, J; Casado, A; de Las Peñas, R; del Muro, XG; López-Pousa, A; Martín, J; Martínez-Trufero, J; Maurel, J; Quintana, MJ, 2004) |
| "Eighteen patients with high grade malignant fibrous histiocytoma (MFH) of bone and 112 patients with high grade osteosarcoma (OS) of the extremity were treated with neoadjuvant chemotherapy comprised of methotrexate, cisplatinum, doxorubicin and ifosfamide." | 3.69 | Neoadjuvant chemotherapy for osseous malignant fibrous histiocytoma of the extremity: results in 18 cases and comparison with 112 contemporary osteosarcoma patients treated with the same chemotherapy regimen. ( Bacci, G; Bertoni, F; Campanacci, M; Cesari, M; Ferrari, S; Forni, C; Gasbarrini, A; Mercuri, M; Sottili, S; Tienghi, A, 1997) |
| "From January 1990 to December 1995 we treated 35 patients (pts) with bone and soft tissue sarcoma with ifosfamide (IFM)." | 3.69 | [The effects of high-dose ifosfamide in the treatment of bone and soft tissue sarcomas]. ( Ishii, T; Kitoh, M; Satoh, T; Tatezaki, S; Umeda, T; Yonemoto, T, 1997) |
| "Malignant fibrous histiocytoma (MFH) is a rare bone tumor usually treated like osteosarcoma." | 2.68 | Neoadjuvant chemotherapy in malignant fibrous histiocytoma of bone and in osteosarcoma located in the extremities: analogies and differences between the two tumors. ( Bacci, G; Ferrari, S; Mercuri, M; Picci, P, 1997) |
| "The role and value of chemotherapy for soft tissue sarcomas remain unclear." | 1.30 | [Chemotherapy for pulmonary metastases of soft tissue sarcoma]. ( Kito, M; Umeda, T, 1998) |
| "A case of malignant fibrous histiocytoma (MFH) of jejunal origin with brain and lung metastases was treated by jejunal resection." | 1.29 | [A case of malignant fibrous histiocytoma of jejunal origin with marked response to cisplatin, ifosfamide and adriamycin]. ( Fujita, A; Isai, H; Kondo, M; Minase, T; Sekine, K; Tagaki, S, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (21.43) | 18.7374 |
| 1990's | 6 (42.86) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Patel, SJ | 1 |
| Lynch, JW | 1 |
| Johnson, T | 1 |
| Carroll, RR | 1 |
| Schumacher, C | 1 |
| Spanier, S | 1 |
| Scarborough, M | 1 |
| Maurel, J | 1 |
| Buesa, J | 1 |
| López-Pousa, A | 1 |
| del Muro, XG | 1 |
| Quintana, MJ | 1 |
| Martín, J | 1 |
| Casado, A | 1 |
| Martínez-Trufero, J | 1 |
| de Las Peñas, R | 1 |
| Balañá, C | 1 |
| Takeuchi, S | 1 |
| Akahoshi, Y | 1 |
| Kasai, C | 1 |
| Nishimoto, Y | 1 |
| Fujita, A | 1 |
| Isai, H | 1 |
| Kondo, M | 1 |
| Minase, T | 1 |
| Tagaki, S | 1 |
| Sekine, K | 1 |
| Bacci, G | 2 |
| Ferrari, S | 2 |
| Bertoni, F | 1 |
| Mercuri, M | 2 |
| Forni, C | 1 |
| Sottili, S | 1 |
| Gasbarrini, A | 1 |
| Tienghi, A | 1 |
| Cesari, M | 1 |
| Campanacci, M | 1 |
| Ishii, T | 1 |
| Tatezaki, S | 1 |
| Satoh, T | 1 |
| Yonemoto, T | 1 |
| Umeda, T | 2 |
| Kitoh, M | 1 |
| Picci, P | 1 |
| Kito, M | 1 |
| Otsuka, K | 1 |
| Hamakawa, H | 1 |
| Sumida, T | 1 |
| Tanioka, H | 1 |
| Neda, H | 1 |
| Maeda, M | 1 |
| Moriya, H | 1 |
| Inohara, T | 1 |
| Fujita, T | 1 |
| Doi, T | 1 |
| Nakajima, T | 1 |
| Tanaka, I | 1 |
| Ohhira, N | 1 |
| Takeda, M | 1 |
| Gotoh, M | 1 |
| Cormier, JN | 1 |
| Patel, SR | 1 |
| Herzog, CE | 1 |
| Ballo, MT | 1 |
| Burgess, MA | 1 |
| Feig, BW | 1 |
| Hunt, KK | 1 |
| Raney, RB | 1 |
| Zagars, GK | 1 |
| Benjamin, RS | 1 |
| Pisters, PW | 1 |
| Halligan, AW | 1 |
| McGuinness, EP | 1 |
| Budach, V | 1 |
| Budach, W | 1 |
| Scheulen, M | 1 |
| Czeglarski, G | 1 |
| Boven, E | 1 |
| Calame, JJ | 1 |
| Molthoff, CF | 1 |
| Pinedo, HM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Pilot Study Investigating Neoadjuvant Temozolomide-based Proton Chemoradiotherapy for High-Risk Soft Tissue Sarcomas[NCT00881595] | Phase 2 | 0 participants (Actual) | Interventional | 2009-02-28 | Withdrawn (stopped due to No patients accrued since study opened) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for ifosfamide and Histiocytoma, Benign Fibrous
| Article | Year |
|---|---|
Concurrent ifosfamide-based chemotherapy and irradiation. Analysis of treatment-related toxicity in 43 patients with sarcoma.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Bone Neoplasms; Child; Child, Preschool; Combined Mo | 2001 |
2 trials available for ifosfamide and Histiocytoma, Benign Fibrous
| Article | Year |
|---|---|
Dose-intense ifosfamide/doxorubicin/cisplatin based chemotherapy for osteosarcoma in adults.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Doxorubicin; Histi | 2002 |
Neoadjuvant chemotherapy in malignant fibrous histiocytoma of bone and in osteosarcoma located in the extremities: analogies and differences between the two tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Arm; Bone Neoplasms; Chemotherapy | 1997 |
11 other studies available for ifosfamide and Histiocytoma, Benign Fibrous
| Article | Year |
|---|---|
Salvage surgical resection after high-dose ifosfamide (HDIF) based regimens in advanced soft tissue sarcoma (ASTS): a potential positive selection bias--a study of the Spanish group for research on sarcomas (GEIS).
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Bias; Clinical Trials, | 2004 |
[Clinical evaluation on the sensitivity test for anti-cancer agents in malignant bone and soft-tissue tumors].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; | 1984 |
[A case of malignant fibrous histiocytoma of jejunal origin with marked response to cisplatin, ifosfamide and adriamycin].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Doxorubicin; Histiocytom | 1993 |
Neoadjuvant chemotherapy for osseous malignant fibrous histiocytoma of the extremity: results in 18 cases and comparison with 112 contemporary osteosarcoma patients treated with the same chemotherapy regimen.
Topics: Adolescent; Adult; Amputation, Surgical; Antibiotics, Antineoplastic; Antimetabolites, Antineoplasti | 1997 |
[The effects of high-dose ifosfamide in the treatment of bone and soft tissue sarcomas].
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Bone Neoplasms; Child; Drug Administration Sch | 1997 |
[Chemotherapy for pulmonary metastases of soft tissue sarcoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Administra | 1998 |
Treatment of mandibular malignant fibrous histiocytoma during pregnancy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cesarean Section; Chemotherapy, Adjuvant; Dac | 2001 |
[A case of retroperitoneal malignant fibrous histiocytoma with marked response to cisplatin, ifosfamide and doxorubicin].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Histiocytoma, Benign Fibrous | 2001 |
Malignant fibrous histiocytoma of the fallopian tube.
Topics: Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Fallopian Tube Neoplasms; Female; Histio | 1990 |
Primary chemosensitivity and secondary drug resistance of xenografted soft part sarcomas.
Topics: Animals; Bleomycin; Doxorubicin; Drug Resistance; Female; Histiocytoma, Benign Fibrous; Humans; Ifos | 1989 |
Characterization and chemotherapy of human soft tissue sarcoma (STS) lines grown in nude mice.
Topics: Animals; Cyclophosphamide; Doxorubicin; Female; Fibrosarcoma; Histiocytoma, Benign Fibrous; Humans; | 1989 |